Janet Bush, | |
2805 Charles Bryan Rd, Bartlett, TN 38134-4756 | |
(901) 384-3386 | |
Not Available |
Full Name | Janet Bush |
---|---|
Gender | Female |
Speciality | Speech-language Pathologist |
Location | 2805 Charles Bryan Rd, Bartlett, Tennessee |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134631377 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
235Z00000X | Speech-language Pathologist | 1663 (Tennessee) | Primary |
Provider Name | Ave Maria Home |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1831250604 PECOS PAC ID: 2365518909 Enrollment ID: O20211028001255 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.
Columbia University Medical Center will present the 2010 Naomi Berrie Award to a Harvard researcher who has made important advances in understanding the molecular basis for links between obesity, diabetes and heart disease. A promising young investigator at Columbia will also be recognized for her novel investigations regarding the basis for disordered lipid metabolism in diabetes.
Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company's FDA filings.
Stanmore Implants, specialists in the design and manufacture of patient specific and modular orthopaedic implants, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sculptor Robotic Guidance Arm for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Janet Bush, 2805 Charles Bryan Rd, Bartlett, TN 38134-4756 Ph: (901) 384-3386 | Janet Bush, 2805 Charles Bryan Rd, Bartlett, TN 38134-4756 Ph: (901) 384-3386 |
News Archive
Regeneron Pharmaceuticals, Inc. today announced that detailed clinical data from the positive Phase 2b portion of the seamless Phase 2/3 MOBILITY trial of sarilumab in rheumatoid arthritis (RA) will be presented at a late-breaking poster session at the upcoming American College of Rheumatology (ACR) Annual Scientific Meeting, which will take place from November 5-9 in Chicago.
Columbia University Medical Center will present the 2010 Naomi Berrie Award to a Harvard researcher who has made important advances in understanding the molecular basis for links between obesity, diabetes and heart disease. A promising young investigator at Columbia will also be recognized for her novel investigations regarding the basis for disordered lipid metabolism in diabetes.
Cannabis Science Inc., a pharmaceutical cannabis company, is pleased to report to their shareholders that the choice of our initial cannabis-based pharmaceutical for FDA clinical trials has been made. The Company has reported several possible drugs for FDA clinical trials. Based on extensive studies, the Company has decided to contract with a group based in Colorado to handle the Company's FDA filings.
Stanmore Implants, specialists in the design and manufacture of patient specific and modular orthopaedic implants, announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Sculptor Robotic Guidance Arm for precision implant placement in unicompartmental knee surgery, also known as partial knee resurfacing.
› Verified 8 days ago
John Bill Spaedt, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2805 Charles Bryan Rd, Bartlett, TN 38134 Phone: 901-701-5995 | |
Mrs. Pamela Sue Mayton, MSCCCSLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3856 Charbon Ln, Bartlett, TN 38133 Phone: 901-371-0139 | |
Jessica Simpson, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2986 Kate Bond Rd, Bartlett, TN 38133 Phone: 901-820-7433 | |
Sarah Ross, M.S. CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 2805 Charles Bryan Rd, Bartlett, TN 38134 Phone: 901-701-5995 | |
Ms. Brenda Joyce Straw, MSP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6025 Stage Rd # 42-210, Bartlett, TN 38134 Phone: 901-831-4626 | |
Leigha Friener, MA-CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2965 N Germantown Rd Ste 124, Bartlett, TN 38133 Phone: 901-683-8787 |